---
figid: PMC12192919__ijms-26-05858-g002
figtitle: Myostatin-mediated muscle atrophy in SMA
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12192919
filename: ijms-26-05858-g002.jpg
figlink: /pmc/articles/PMC12192919/figure/F2/
number: F2
caption: Myostatin-mediated muscle atrophy in SMA. SMA—Spinal Muscular Atrophy; proMSTN—Inactive
  precursor of Myostatin; MSTN—Myostatin (Growth Differentiation Factor 8, GDF-8);
  ActRIIB—Activin Receptor Type IIB; SMAD2/3—SMAD Family Members 2 and 3 (transcription
  factors activated by TGF-β signaling); MAPK—Mitogen-Activated Protein Kinase signaling
  pathway; JNK—c-Jun N-terminal Kinase; ERK—Extracellular Signal-Regulated Kinase;
  p38—p38 Mitogen-Activated Protein Kinase; MuRF1—Muscle RING-Finger Protein-1 (muscle-specific
  E3 ubiquitin ligase involved in atrophy); Atrogin1—Also known as FBXO32, a muscle-specific
  ubiquitin ligase involved in muscle protein degradation
papertitle: 'Myostatin Modulation in Spinal Muscular Atrophy: A Systematic Review
  of Preclinical and Clinical Evidence'
reftext: Martina Gnazzo, et al. Int J Mol Sci. 2025 Jun;26(12).
year: '2025'
doi: 10.3390/ijms26125858
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: spinal muscular atrophy | myostatin inhibition | SMN-targeted therapy |
  muscle atrophy | apitegromab | motor function restoration | adjunctive treatment
  strategy
automl_pathway: 0.9309548
figid_alias: PMC12192919__F2
figtype: Figure
redirect_from: /figures/PMC12192919__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12192919__ijms-26-05858-g002.html
  '@type': Dataset
  description: Myostatin-mediated muscle atrophy in SMA. SMA—Spinal Muscular Atrophy;
    proMSTN—Inactive precursor of Myostatin; MSTN—Myostatin (Growth Differentiation
    Factor 8, GDF-8); ActRIIB—Activin Receptor Type IIB; SMAD2/3—SMAD Family Members
    2 and 3 (transcription factors activated by TGF-β signaling); MAPK—Mitogen-Activated
    Protein Kinase signaling pathway; JNK—c-Jun N-terminal Kinase; ERK—Extracellular
    Signal-Regulated Kinase; p38—p38 Mitogen-Activated Protein Kinase; MuRF1—Muscle
    RING-Finger Protein-1 (muscle-specific E3 ubiquitin ligase involved in atrophy);
    Atrogin1—Also known as FBXO32, a muscle-specific ubiquitin ligase involved in
    muscle protein degradation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMN1
  - MSTN
  - ACVR2B
  - SMAD2
  - SMAD3
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK1
  - MAPK3
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TRIM63
---
